Gary Musso
35Patents
15h-index
38Co-inventors
81Inventor score
Filing activity: Dec 28, 1984 → Mar 22, 2022
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US5268164A | Increasing blood-brain barrier permeability with permeabilizer peptides | Chemistry; Metallurgy | 177 | Expired |
| US5506206A | Increasing blood-brain barrier permeability with permeabilizer peptides | Chemistry; Metallurgy | 150 | Expired |
| US5854204A | A.beta. peptides that modulate .beta.-amyloid aggregation | Human Necessities | 118 | Expired |
| US5686416A | Increasing blood-brain barrier permeability with permeabilizer peptides | Chemistry; Metallurgy | 104 | Expired |
| US6303567A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Human Necessities | 89 | Expired |
| US5817626A | Modulators of beta-amyloid peptide aggregation | Human Necessities | 87 | Expired |
| US5854215A | Modulators of .beta.-amyloid peptide aggregation | Human Necessities | 70 | Expired |
| US5985242A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Human Necessities | 64 | Expired |
| US6180608A | Pharmaceutical formulations for sustained drug delivery | Performing Operations; Transporting | 60 | Expired |
| US5968895A | Pharmaceutical formulations for sustained drug delivery | Performing Operations; Transporting | 52 | Expired |
| US6319498A | Modulators of amyloid aggregation | Human Necessities | 36 | Expired |
| US4833251A | Compounds for tagging nucleic acid probes | Chemistry; Metallurgy | 28 | Expired |
| US4835252A | Vasoactive intestinal peptide analogs | Emerging Cross-Sectional Technologies | 20 | Expired |
| US4780405A | Carbonic anhydrase inhibitor-tagged nucleic acid probes | Physics | 16 | Expired |
| US5130446A | Fluorescent compounds for tagging nucleic acid probes | Chemistry; Metallurgy | 15 | Expired |
| US4939224A | Vasoactive intestinal peptide analogs | Human Necessities | 13 | Expired |
| US6277826A | Modulators of .beta.-amyloid peptide aggregation comprising D-amino acids | Physics | 13 | Expired |
| US5210203A | Sulfonamide-derivative compounds for tagging nucleic acid probes | Chemistry; Metallurgy | 9 | Expired |
| US10493047B2 | Stable aqueous capsaicin injectable formulations and medical uses thereof | Human Necessities | 7 | Active |
| US7598343B1 | Pharmaceutical formulations of bivalirudin and processes of making the same | Human Necessities | 7 | Active |
| US6699833B1 | Pharmaceutical formulations for sustained drug delivery | Performing Operations; Transporting | 6 | Expired |
| US6689752B2 | Modulators of &bgr;-amyloid peptide aggregation comprising D-amino acids | Physics | 6 | Expired |
| US7582727B1 | Pharmaceutical formulations of bivalirudin and processes of making the same | Human Necessities | 5 | Active |
| US7658917B2 | Modulators of amyloid aggregation | Human Necessities | 4 | Expired |
| US10765649B2 | Stable aqueous capsaicin injectable formulations and medical uses thereof | Human Necessities | 4 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.